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OBJECTIVE
The extent of previously published studies comparing static intensity-modulated radiotherapy (IMRT) 
and volumetric modulated arc therapy (VMAT) in the adjuvant setting of endometrial cancer is limited 
and reports do not cover the whole landscape of today’s clinical practice. The aim of this study was to 
compare these treatment techniques.
METHODS
Using 12 image sets, VMAT with double arcs and IMRT with 7 fields were planned. The femoral heads, 
rectum, bladder, iliac bone marrow, and bowels were contoured as organs at risk (OARs). Planned treat-
ment volume (PTV) was prescribed to be 45 gray (Gy). Target and OAR parameters, conformity, and 
homogeneity indices were evaluated. P value under 0.05 was considered statistically significant.
RESULTS
Objectives for target volumes were achieved. No significant differences were found in conformity in-
dex, maximum dose (Dmax), or integral dose. Homogeneity index was better with IMRT (1.06 vs. 1.07; 
p<0.01). Dose received by 2% volume of PTV (D2%), D5%, the volume receiving 107% of prescribed dose 
(V107%), and V105% were lower with IMRT (p<0.05). PTV D98%, percent volume receiving ≥45 Gy (V45 Gy), 
and clinical target volume V45 Gy were higher with VMAT (p<0.05). Regarding OARs, only rectum V40 
Gy, rectum PTV V40 Gy, and dose volume parameter D2cc were lower with VMAT (p<0.05). VMAT was 
superior with respect to monitor units and beam-on time per fraction: 465 vs. 1689 and 166 vs. 338 
seconds, respectively (p<0.001).
CONCLUSION
Static IMRT is superior to VMAT regarding homogeneity, Dmax and OAR sparing, except for the rec-
tum and the bladder. However, it is a marginal benefit with small differences. VMAT remains an attrac-
tive solution due to low number of monitor units needed and shorter treatment duration, which allows 
more time for patient imaging and positioning.
Keywords: Intensity-modulated radiotherapy; volumetric modulated arc therapy; endometrial cancer; radiothera-
py; gynecological neoplasms.
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involved lymph node or positive surgical margin 
(no indication of external beam boost dose). Com-
puterized Tomography (CT) images were acquired 
in supine position with 2.5 mm slice thickness us-
ing General Electric Lightspeed model CT simulator 
(General Electric Company, Easton Turnpike, US). 
All patients were scanned with empty rectum and 
full bladder. The cranial and caudal borders of the 
CT scan were the upper border of L3 vertebra and 
proximal third of femurs, respectively.
Treatment planning
CT images were transferred to Varian Eclipse software 
(version 8.6.15 - Varian Medical Systems, Palo Alto, 
CA – US). Contouring of the Clinical Target Volume 
(CTV) and organs at risk (OARs) were done by the 
same physician in accordance with RTOG atlases.[5,6] 
OARs included: rectum, iliac crests, small bowel, femo-
ral heads and bladder. In addition to OARs, OAR mi-
nus Planning Treatment Volume (PTV) structures were 
also created. Iliac crests were delineated for assessment 
of dose to iliac bone marrow (BM) where contouring 
was done including the whole bony structure. Follow-
ing dose constrains were used for planning: rectum V40 
Gy <50%, Dmax <50 Gy; BM V10 Gy <90%, V20 Gy <75 Gy; 
small bowel V45 Gy ≤200 cc, Dmax <50 Gy; femoral heads 
Dmax <50 Gy, V40 Gy <40%, V45 Gy <25%; bladder V40 Gy 
<50%, Dmax <50 Gy.
PTV was automatically created with 1 cm margin 
added to CTV. Dose prescription to PTV was set as 45 
Gy in 25 fractions. No more than 0.03 cc in a conflu-
ent volume was allowed to receive more than 110% of 
prescribed dose. There was an exception in the vaginal 
cuff region where we set the upper limit to 115%. No 
more than 0.03 cc of PTV was allowed to receive less 
than 93% of the target dose. 6 MV photon energy was 
used. All static IMRT plans were made with 7 field ar-
rangement and VMAT plans with double-arc.
For the standardization of integral dose calculation, 
external body contours were restricted to 3.5 cm above 
and below the PTV volume. PTV was subtracted from 
this cropped body contour. The resulting volume was 
used for integral dose calculation.
Planning optimization and dose calculations were 
done with Eclipse software (version 8.6.15). For both 
techniques, multi-leaf collimators (MLC) were used in 
dynamic mode. MLCs consist of 120 leaves which are 
0.5 cm thick at the isocenter for the central 20 cm, and 
1 cm in the outer 2x10 cm (maximum leaf speed 2.5 
cm/s and leaf transmission of 1.6%; maximum gantry 
speed of 5.54°/s).
Introduction 
Endometrial cancer is the most common gynecologic 
cancer in women between ages 55 and 85 in developed 
countries.[1,2] Only 5% of patients are younger than 
40 years old.[2] According to actual guidelines, stan-
dard treatment consists of surgery±radiotherapy±ch
emotherapy in case of non-metastatic operable cases.
[3] Technological advancements in radiotherapy made 
3D conformal (3DCRT) and intensity modulated ra-
diotherapy (IMRT) techniques available. The use of 
these new techniques allow sparing the organs at risk 
(OARs) situated in the proximity of target volume from 
ionizing radiation better, therefore reducing the acute 
and late toxicity.
Today, treatment of endometrial cancer in the post-
operative setting is widely done with 3DCRT. Free con-
touring atlases for the delineation of OARs and target 
volumes are available online.[4–6] IMRT is reported to 
be even superior to 3DCRT regarding acute gastroin-
testinal and hematological toxicities.[7,8] A study per-
formed with 36 mixed gynecologic cases showed less 
chronic gastrointestinal toxicity and complication rates 
with IMRT, and RTOG 0418 is the first published mul-
ticenter phase II study proving the feasibility of IMRT 
for this group of patients in routine practice.[9,10]
Volumetric Modulated Arc Therapy (VMAT) is 
an advanced form of IMRT where irradiation contin-
ues while the gantry is rotating around the patient. 
Studies including various gynecological malignan-
cies showed dosimetric superiority of VMAT to static 
IMRT regarding OARs.[11,12] However the number 
of published studies and endometrial cancer cases in-
cluded are limited. Moreover, the methods used and 
parameters evaluated do not match our standard clini-
cal practice. Therefore we needed to compare static 
IMRT technique with double-arc VMAT on previously 




Twelve previously treated early stage endometrial 
cancer cases who had previous post-operative pel-
vic external beam radiation without para-aortic 
treatment indication were selected for the analysis. 
The study was approved by the local Ethics Com-
mittee in accordance with the Helsinki Declaration. 
All patients had proper surgery in accordance with 
oncological principles without any residual mass, 
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IMRT
For the IMRT plans; 7 gantry angles were chosen (30°, 
80°, 130°, 180°, 230°, 280°, 330°) using sliding win-
dow technique. Isocenter was the center of the PTV 
volume. Maximum dose rate was 300 MU/min. Dose 
constrains were defined for PTV, OARs and OAR-PTV 
volumes in accordance of priority, where rectum had 
the maximum priority among OARs. Body-PTV vol-
ume had also dose constrains in order to limit any hot 
spots. Anisotropic Analytical Algorithm (AAA) pho-
ton dose calculation algorithm was used for all plans.
[13–15] The dose calculation grid was set to 2.5 mm.
VMAT
Same photon energy, isocenter point and dose con-
strains as for the IMRT were used for VMAT plans to 
achieve the optimal solution. Progressive Resolution 
Optimization (PRO) algorithm used for the optimiza-
tion process calculates in 177 control points with 2° 
intervals. After the optimization dose calculation grid 
was set to 2.5 mm and AAA was used.
Two arcs with 181°–179° clockwise and 179°–181° 
counterclockwise rotations were used with maximum 
dose rate of 600 MU/min. To minimize the ‘tongue and 
groove’ effect 45° collimator angle was used.
Evaluation and statistical analysis
Evaluation of plans was done over standard dose-vol-
ume histograms (DVHs) and with examination of all 
slices. Homogeneity and conformity indices were cal-
culated with the formulas proposed by RTOG: Homo-
geneity Index (HI)=[maximum isodose in the target]/
[reference isodose], Conformity Index (CI)=[volume 
of reference isodose]/[target volume].[16] Normal 
distribution pattern of each parameter was measured 
with Saphiro-Wilk Test. Two-tailed paired Student’s t 
Test was used for normally distributed data, and two-
tailed non-parametric paired tests for the remaining 
(Wilcoxon Signed-Rank and Sign Test for symmetric 
and asymmetric distributed data, respectively). All sta-
tistical analysis were performed using JMP 9.0 (SAS 
Institute Inc. North Carolina, US). Two-sided p values 
under 0.05 were considered as statistically significant.
Results
Mean PTV volume was 1477±130 cc. Comparative re-
sults of IMRT and VMAT techniques are presented in 
Tables 1–3. Because of the abundance of normally dis-
tributed data, standard deviation was preferred to in-
terquartile range in the tables. A retrospective analysis 
revealed that the study had 88% power to detect 1 Gy 
difference between two techniques for the OARs.
Target Coverage, Dose Distributions, 
MU and Beam-on-time (Tables 1, 2)
Between IMRT and VMAT, there was no significant 
difference in mean CI, Dmax (global maximum dose), 
integral dose and PTV V95% (volume receiving 95% of 
the prescribed dose) or CTVmin (minimum point dose 
CTV receives). Mean HI, PTV D2% (highest dose cov-
ering 2% of PTV), PTV D5%, PTV D98%, PTV V107%, 
PTV V105%, PTV V45 Gy (percent of volume receiving at 
least 45 Gy) and CTV V45 Gy were significantly lower 
with IMRT. MU and beam-on-time per fraction were 
markedly lower with VMAT technique. It shall be also 
noted that each IMRT field setup required additional 
time (not measured).
Organs at Risk (Table 3) (Only results with 
p<0.05 are presented in Table 3) 
Small bowel: Slight but statistically significant mean dif-
Table 1 MU/fx, beam on time/fx, integral dose and global dose distribution 
Parameter (unit or ratio*) n IMRT VMAT t M S p 
   Mean±SD Mean±SD
Conformity Index 12 1.08±0.04 1.09±0.04   19 0.151
Homogeneity Index 12 1.06±0.01 1.07±0.01 3.94   0.002
Dmax 12 1.09±0.02 1.09±0.01   22 0.092
Dmax (Gy) 12 49.14±0.74 49.43±0.59   22 0.092
Integral dose (Gy x cc) 10¥ 329837±99295 328068±87985 -0.27   0.792
MU/fx 12 1689±341 465±38 -12.84   <0.001
Beam on time/fx (sec) 12 338±68 166±0.67  -6  0.001
t, M and S: Results of Student’s t, Sign and Wilcoxon Signed-Rank tests, respectively; *: Parameters without a unit are ratios. ¥: Two patients had CT images with 
a cranial border of less than 3.5 cm above the PTV; Dmax: maximum dose; fx: Fraction; VMAT: Volumetric modulated arc therapy; IMRT: Intensity modulated radio-
therapy; MU: Monitor units; SD: Standard deviation.
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Femoral heads: D2cc, D2% and V45 Gy of only left femo-
ral heads were significantly lower with IMRT. However 
there was also a trend towards statistical significance 
(p=0.079) in D2cc and D2% of the right side.
Discussion
In this study, 7-field static IMRT and double-arc VMAT 
techniques are compared using image sets of 12 pre-
viously treated patients having endometrial cancer in 
post-operative setting. Retrospectively, dosimetric and 
clinical superiority of IMRT to 3DCRT regarding small 
ferences were observed in small bowels Dmax, D2%, D2cc 
and in favor (lower) of IMRT. D2cc and V45 Gy of ‘small 
bowel – PTV structures’ were also lower with IMRT.
Iliac BM: Dmax, D2%, D2cc of BM and D2cc, V45 Gy of 
BM-PTV were significantly lower with IMRT
Bladder: No significance found in mean difference 
of parameters regarding bladder.
Rectum: Results related with the parameters of rec-
tum were against the general trend. Only rectum Dmax 
was lower with IMRT. On the contrary; rectum V40 Gy, 
rectum-PTV V40 Gy and D2cc were lower with VMAT, all 
reaching statistical significance.
Table 2 Dosimetric comparison of target volume parameters 
Parameter (unit or ratio*) n IMRT VMAT t M p 
   Mean±SD Mean±SD
PTV D2% (Gy) 12 47.7±0.42 48.35±0.52 3.94  0.002
PTV D5% (Gy) 12 47.41±0.42 48.09±0.49 4.07  0.002
PTV D98% (Gy) 12 44.49±0.34 44.74±0.3 2.71  0.020
PTV V107%  12 0.01±0.02 0.08±0.08  4 0.039
PTV V105%  12 0.13±0.14 0.40±0.25  5 0.006
PTV V95%  12 0.998±0.002 0.998±0.002  -3 0.146
PTV V45 Gy 12 0.96±0.01 0.97±0.01 3.34  0.007
CTV minimum (Gy) 12 43.98±0.71 44.48±0.28 2.03  0.068
CTV V45 Gy 12 0.99±0.01 0.999±0.002  4 0.039
t, and M: Results of Student’s t and Sign Test, respectively; *: Parameters without a unit are ratios; CTV: Clinical treatment volume; Dx%: Maximum dose covering 
x% of the volume; VMAT: Volumetric modulated arc therapy; IMRT: Intensity modulated radiotherapy; PTV: Planned treatment volume; SD: Standard deviation; 
Vx%: Volume covered by at least x% of the dose; Vx Gy: Volume covered by at least x Gy isodose.
Table 3 Dosimetric comparison of OAR parameters (only significant values) 
Parameter (unit or ratio*) n IMRT VMAT t M p 
   Mean±SD Mean±SD
Bowel Dmax (Gy) 12 48.35±0.85 49.09±0.60 3.16  0.009
Bowel D2% (Gy) 12 46.27±1.31 46.94±1.62  4 0.039
Bowel D2cc (Gy) 12 47.5±0.62 48.22±0.64 3.76  0.003
Bowel-PTV D2cc (Gy) 12 45.67±0.06 46.48±1.53 2.76  0.018
Bowel-PTV V45 Gy (cc) 12 8.01±9.07  25.87±21.22  5 0.006
BM D2% (Gy) 12 46.93±0.3 47.45±0.47 3.21  0.008
BM V10 Gy 12 0.95±0.06 0.99±0.02  5 0.006
BM-PTV D2% (Gy) 12 44.83±1.2 47.45±0.47 6.45  <0.001
BM-PTV V10 Gy  12 0.95±0.07 0.99±0.02  5 0.006
Rectum Dmax (Gy) 12 47.79±0.54 48.45±0.58 2.96  0.013
Rectum V40 Gy 12 0.59±0.14 0.51±0.144 -3.4  0.006
Rectum-PTV D2cc (Gy) 12 42.22±4.2 40.66±5.39  -4 0.039
Rectum-PTV V40 Gy 12 0.21±0.13 0.12±0.11  -6 0.001
Left femur D2cc (Gy) 12 42.81±1.76 44.61±1.97 3.56  0.004
Left femur D2% (Gy) 12 41.96±2 43.93±2.42 3.29  0.007
Left femur V45 Gy 12 0.006±0.008 0.02±0.02  5 0.006
t, and M: Results of Student’s t and Sign tests, respectively; *: Parameters without a unit are ratios. Dmax: Maximum dose; Dx%: Maximum dose covering x% of the 
volume; Dx cc: Maximum dose covering x cc of the volume; OAR: Organ at risk; SD: Standard deviation; Vx Gy: Volume covered by at least x Gy isodose.
bowel, pelvic BM, bladder, rectum and femoral heads is 
already investigated and shown in gynecologic malig-
nancies having indication for external pelvic radiation.
[7–9,17–21] Likewise, dose coverage of PTV, integral 
doses, HI and CI were compared in these former stud-
ies.[12] All taken into consideration, it can be clearly 
stated that IMRT is superior to 3DCRT especially re-
garding toxicity and CI. Therefore we did not need to 
include the 3DCRT technique into consideration in our 
study. In phase II RTOG 0418 study it is reported that 
IMRT technique for endometrial cancer in post-oper-
ative setting is practically feasible and should be pre-
ferred with proper education and standardization.[10]
VMAT techniques were developed after imple-
mentation of IMRT. Over the past ten years they were 
compared to IMRT and 3DCRT, Wong et al., compared 
VMAT, IMRT and 3DCRT.[11,12] The study included 
5 post-operative endometrial cancer cases, some of 
them treated with para-aortic volumes as well. The arc 
technique consisted of 30–300° and 60–330° gantry ar-
rangements and the IMRT was delivered with 8 fields. 
There were no significant difference between IMRT 
and VMAT. Both of them were superior to 3DCRT 
regarding the small bowel and iliac BM doses. Unlike 
that, we used 7-field IMRT setup and did not restrict 
the angular arrangement of VMAT. With the use of 
static IMRT we observed significant reduction in doses 
to small bowel (Dmax: 48.35 vs. 49.09 Gy, D2%: 46.27 vs. 
46.94 Gy, D2cc: 47.5 vs. 48.22 Gy, V45: 180.97 vs. 219.31 
cc) and iliac BM (D2%: 46.93 vs. 47.45 Gy, V10 Gy: 95% 
vs. 99%) compared to VMAT. In our study, formula de-
fined by RTOG was used for HI calculation (maximum 
isodose volume/reference isodose volume) and HI was 
better with static IMRT over VMAT (1.06 and 1.07, re-
spectively). Wong et al., used a different formula (dose 
difference between D5% and D95% of PTV) and their 
results were in favor of IMRT against VMAT as well 
(7.5% dose difference vs. 11%, respectively).[11]
Cozzi et al., compared single-arc VMAT and IMRT 
in 8 cases with cervix cancer who were treated with 
chemo-radiation.[12] The prescription was 50.4 Gy 
in 28 fractions to PTV. Results were in favor of static 
IMRT both for CI and the doses to OAR. They re-
ported significant reduction in V40 Gy of small bowel 
and ‘small bowel-PTV’ with VMAT in contrast to our 
study which resulted with better Dmax, D2%, D2cc of small 
bowel and D2cc, V45 Gy of ‘small bowel-PTV’ with IMRT 
(Table 3). We could not find any difference in parame-
ters of bladder whereas Cozzi et al., reported reduction 
in D2% of ‘bladder-PTV’, V40 Gy of bladder and ‘bladder-
PTV’ with VMAT.[12] Both studies showed reduction 
in V40 Gy of rectum, V40 Gy and D2cc of ‘rectum-PTV’ with 
VMAT (51% vs. 59%, 12% vs. 21% and 40.66 Gy vs. 
42.22 Gy respectively in our study). Although there is a 
decrease in dose to femoral heads in our study, it does 
not have any clinical importance.
For the parameters of PTV, Cozzi et al., reported 
no difference in D98% and V95% between two techniques 
but a superiority of VMAT for in D2%.[12] In our study 
parameters representing maximal doses like D2%, D5%, 
V107% and V105% were lower with IMRT. On the other 
hand, with higher D98%, PTV V45 Gy, CTV V45 Gy and 
CTVmin, VMAT was capable of delivering better dose 
coverage (Table 2). We think that the main underly-
ing reason for this distinction is the difference of PTV 
and anatomy between cervical and post-operative en-
dometrial cancers. Additionally, it should be noted that 
Cozzi et al., did not define the pelvic BM as OAR and 
used another formula than RTOG for the calculation 
of CI and HI.
Yang et al., also compared 3DCRT, IMRT and a 
conformal double-arc technique on 10 cases with post-
operative endometrial cancer.[22] They made plans 
with an optimization for 50 Gy to ≥95% of the PTV. 
Regarding OAR parameters, arc plans had better re-
sults than 3DCRT and worse results than IMRT plans. 
But the arc technique used in this study was a rotational 
conformal modality with neither inverse planning nor 
intensity modulation. Mean MU for 3DCRT, arc and 
IMRT was reported as 240, 451 and 877 MU, respec-
tively. Our results for MU/fraction and ‘beam on time’ 
(IMRT/VMAT: 1688.58/465.5 MU and 337.72/166.42 
seconds) are in concordance with the results of Cozzi 
et al., showing a marked advantage of VMAT.[12] Risk 
of secondary malignancy due to higher MU of IMRT 
versus slightly higher toxicity risk with VMAT (except 
for rectum) is an issue open to discussion.
A recent dosimetric study by Sharfo et al., com-
pared different IMRT and VMAT strategies on 10 cer-
vix cancer patients using automated in-house planning 
software.[23] The planning goal was to achieve highly 
conformal plans while sparing the OARs with a higher 
priority for the small bowel. The treatment delivery 
time was shorter with VMAT, but with IMRT supe-
rior plan quality was observed. Although performed 
on cervix and not on endometrial cancer patients, for 
us the results of this original work have profound im-
portance, since they depend on an unbiased fully au-
tomated software solution where modern techniques 
were compared. In their conclusions, the authors also 
emphasized the importance of the trade-off between 
the plan quality and treatment delivery.
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tiple hypothesis testing was performed neither in any 
of the previously published studies nor in our study. 
If we were to interpret our results with a strongly con-
servative Bonferroni correction, results with p>0.0008 
should be discarded. This would leave only the differ-
ences in MU/fraction, beam on time and BM-PTV D2% 
parameters as statistically significant.
Conclusions
In this dosimetric study, we could achieve our primary 
objectives with both techniques for the treatment vol-
umes regarding HI, CI, target dose, hot and cold spots. 
Static IMRT plans had slightly but significantly better 
results for some OAR parameters except for rectum. 
On the other hand, VMAT plans were clearly superior 
regarding lower MU and less treatment time. In our 
opinion, as we evaluate all the parameters from a clini-
cal and holistic point of view, static IMRT technique 
provides only a statistical and marginal dosimetric 
benefit against the advantages of VMAT. VMAT re-
mains to be an attractive solution for the adjuvant ex-
ternal beam treatment of endometrial cancer.
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